These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 82892)

  • 1. Reversible dialysis encephalopathy: role for aluminium-containing gels.
    Masselot JP; Adhemar JP; Jaudon MC; Kleinknecht D; Galli A
    Lancet; 1978 Dec 23-30; 2(8104-5):1386-7. PubMed ID: 82892
    [No Abstract]   [Full Text] [Related]  

  • 2. [Water purification in dialysis treatment. Aluminum and encephalopathy].
    Hagstam KE; Lindergård B; Lindholm T; Thysell H
    Lakartidningen; 1980 Jun; 77(26-27):2425-7. PubMed ID: 7401791
    [No Abstract]   [Full Text] [Related]  

  • 3. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
    Parkinson IS; Ward MK; Feest TG; Fawcett RW; Kerr DN
    Lancet; 1979 Feb; 1(8113):406-9. PubMed ID: 84261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-aluminium concentration in dialysis encephalopathy.
    McDermott JR; Smith AI; Ward MK; Parkinson IS; Kerr DN
    Lancet; 1978 Apr; 1(8070):901-4. PubMed ID: 76845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
    Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
    Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
    [No Abstract]   [Full Text] [Related]  

  • 6. Dialysis encephalopathy: recovery after interruption of aluminium intake.
    Poisson M; Mashaly R; Lebkiri B
    Br Med J; 1978 Dec; 2(6152):1610-1. PubMed ID: 728750
    [No Abstract]   [Full Text] [Related]  

  • 7. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 8. Dialysis dementia, aluminium, and tetrahydrobiopterin metabolism.
    Bone I; Thomas M
    Lancet; 1979 Apr; 1(8119):782. PubMed ID: 86025
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of orally administered aluminium hydroxide and results of withdrawal.
    Bournerias F; Monnier N; Reveillaud RJ
    Proc Eur Dial Transplant Assoc; 1983; 20():207-12. PubMed ID: 6657657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of dialysis encephalopathy with deferoxamine].
    Starkstein S; Berthier M; Nogués M; Leiguarda R
    Medicina (B Aires); 1986; 46(3):327-31. PubMed ID: 3574092
    [No Abstract]   [Full Text] [Related]  

  • 11. Dialysis encephalopathy.
    Masramón J; Ricart MJ; Caralps A; Lloveras J; Andreu J; Brulles A; Solá R
    Lancet; 1978 Jun; 1(8078):1370. PubMed ID: 78143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Water purification in dialysis treatment. Aluminum, chemistry, metabolism and toxicity].
    Ganrot PO
    Lakartidningen; 1980 Jun; 77(26-27):2430-1. PubMed ID: 7401794
    [No Abstract]   [Full Text] [Related]  

  • 13. The dialysis encephalopathy syndrome. Possible aluminum intoxication.
    Alfrey AC; LeGendre GR; Kaehny WD
    N Engl J Med; 1976 Jan; 294(4):184-8. PubMed ID: 1244532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis encephalopathy in a non-dialysed uraemic boy treated with aluminium hydroxide orally.
    Nathan E; Pedersen SE
    Acta Paediatr Scand; 1980 Nov; 69(6):793-6. PubMed ID: 7211365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.
    Ward MK; Feest TG; Ellis HA; Parkinson IS; Kerr DN
    Lancet; 1978 Apr; 1(8069):841-5. PubMed ID: 76795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminum toxicity in relation to kidney disorders.
    King SW; Savory J; Wills MR
    Ann Clin Lab Sci; 1981; 11(4):337-42. PubMed ID: 7023347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.
    Parkinson IS; Ward MK; Kerr DN
    J Clin Pathol; 1981 Nov; 34(11):1285-94. PubMed ID: 7320226
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology of aluminium toxicity in a 'low incidence' area.
    Winney RJ; Cowie JF; Cumming AD; Short AI; Smith GD; Robson JS
    Contrib Nephrol; 1984; 38():47-58. PubMed ID: 6713900
    [No Abstract]   [Full Text] [Related]  

  • 19. [Development of dialysis in Sweden. The problem of water purification].
    Erlanson P
    Lakartidningen; 1980 Jun; 77(26-27):2420. PubMed ID: 7401788
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
    Nielsen LP; Heaf JG
    Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.